top of page
Search Results

279 items found for "C-C motif chemokine ligand 17"

  • Illuminating GPCR Research: FRET and BRET-Based Sensors Shed Light on Cellular Signaling

    These biosensors have facilitated the investigation of various aspects of GPCR signaling, including ligand binding (e.g NanoBRET ligand binding [5]), effector protein recruitment assays (e.g G protein recruitment Galés, C., et al., Real-time monitoring of receptor and G-protein interactions in living cells.  Nat Methods, 2005. 2(3): p. 177-84. 7.     

  • Constitutive, Basal, and β-Alanine-Mediated Activation of the Human Mas-Related G Protein-Coupled ..

    MRGPRD was investigated further by probing downstream signaling effectors along the Gαq/Phospholipase C Additionally, we investigated the constitutive (ligand-independent) and basal activity of MRGPRD and

  • Label-free LC-MS based assay to characterize small molecule compound binding to cells

    Study of small molecule binding to live cells provides important information on the characterization of ligands coupled receptor (GPCR), we used one antagonist as probe and multiple other antagonists as competitor ligands Competition binding analysis by titration of five known ligands suggested a good correlation with their This versatile method allows quantitative characterization of ligand binding to cell surface expressed

  • Profiling Immune Cell and Platelet Transcriptomes

    For instance, the expression of specific chemokine receptors in monocytes and macrophages indicates their to elucidate their specific contributions.Moreover, the study's findings on the unique expression of chemokine

  • Intermolecular Interactions in G Protein-Coupled Receptor Allosteric Sites at the Membrane Interface

    receptor-lipid interface represent an uncharacteristic binding location that raises many questions about the ligand Although ligand-lipid interactions are weak, lipid tails play a role in ligand binding pose stability We discuss physicochemical aspects of ligand binding at the receptor-lipid interface and suggest a compound library enriched by weak donor groups for ligand search in such sites."

  • 📰 GPCR Weekly News, September 25 to October 1, 2023

    by NMR spectroscopy with stable-isotope labeled receptors GPCR Binders, Drugs, and more Orthosteric ligand Annual Meeting IRN I-GPCRNet November 2 - 4, 2023 | GPCR Retreat- Registration Closed November 15 - 17 Meeting February 3 - 7, 2024 | SLAS2024 International Conference and Exhibition March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating Conference April 5 - 10, 2024 | AACR Annual Meeting May 13 - 17, 2024 | 20th Annual PEGS Boston Summit

  • G protein-coupled receptor interactions and modification of signalling involving the ghrelin ...

    G protein-coupled receptor interactions and modification of signalling involving the ghrelin receptor Known roles of GHSR1a now extend to regulation of neurogenesis, learning and memory, gastrointestinal motility , glucose/lipid metabolism, the cardiovascular system, neuronal protection, motivational salience, and

  • 📰 GPCR Weekly News, October 2 to 8, 2023

    Annual Meeting IRN I-GPCRNet November 2 - 4, 2023 | GPCR Retreat- Registration Closed November 15 - 17 Meeting February 3 - 7, 2024 | SLAS2024 International Conference and Exhibition March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating Conference April 5 - 10, 2024 | AACR Annual Meeting May 13 - 17, 2024 | 20th Annual PEGS Boston Summit

  • Do You Believe AI Could Accelerate Drug Discovery?

    However, the impact on structure-based ligand discovery remained uncertain due to the necessity for accurately found that AF2 models achieved accurate side-chain predictions and successfully docked high-affinity ligands models like AlphaFold3, which can predict complex protein-molecule interactions and post-translational modifications AlphaFold2 structures guide prospective ligand discovery.

  • Dynamic recognition of naloxone, morphine and endomorphin1 in the same pocket of µ-opioid receptors

    metadynamics-enhanced conformational sampling are used here to determine the different interactions of these two ligands The endogenous peptide ligand endomorphin-1 (EM-1) underwent almost no significant conformational changes This finding reveals a dynamic mechanism for the response of MOR to different ligands and provides a basis for the discovery of new ligands for MOR at the atomic level."

  • Membrane Lipids Are an Integral Part of Transmembrane Allosteric Sites in GPCRs: A Case Study of...

    Ligands must first partition into the surrounding membrane and take lipid paths to these sites. Remarkably, a significant part of the bound ligands appears exposed to the membrane lipids. experimental structures do not usually account for the surrounding lipids, and their apparent contribution to ligand

  • 📰 GPCR Weekly News, May 13 to 19, 2024

    Lyu, Brian Shoichet, Bryan Roth, et al. for their research on AlphaFold2 structures guide prospective ligand Signaling Constitutive internalisation of EP2 differentially regulates G protein signalling ArreSTick motif of the Prototypic G Protein-Coupled Adenosine A2A Receptor AlphaFold2 structures guide prospective ligand 2024 | 9th GPCRs in Medicinal Chemistry October 23 - 25, 2024 | 11th Adhesion GPCR Workshop July 12 - 17

  • Biphasic activation of β-arrestin 1 upon interaction with a GPCR revealed by methyl-TROSY NMR

    in the function of G protein-coupled receptors (GPCRs). βarrs typically interact with phosphorylated C-terminal tail (C tail) and transmembrane core (TM core) of GPCRs. However, the effects of the C tail- and TM core-mediated interactions on the conformational activation Our NMR analyses demonstrated that while the C tail-mediated interaction alone induces partial activation in which βarr exists in equilibrium between basal and activated conformations, the TM core- and the C

  • 📰 GPCR Weekly News, April 3 to 9, 2023

    GPCR Activation and Signaling Phosphorylation barcodes direct biased chemokine signaling at CXCR3. Binders, Drugs, and more Inhibiting a promiscuous GPCR: iterative discovery of bitter taste receptor ligands

  • G protein coupling and activation of the metabotropic GABAB heterodimer

    September 2022 "Metabotropic γ-aminobutyric acid receptor (GABABR), a class C G protein-coupled receptor However, little is known about the mechanism for GP coupling and activation for class C GPCRs. This mechanism provides fresh insights into the mechanistic details of class C GPCRs activation expected

  • 📰 GPCR Weekly News, March 20 to 26, 2023

    A snake toxin as a theranostic agent for the type 2 vasopressin receptor Small-Molecule Fluorescent Ligands for the CXCR4 Chemokine Receptor.

  • 📰 GPCR Weekly News, May 15 to 21, 2023

    GPCR Activation and Signaling Monitoring the Reversibility of GPCR Signaling by Combining Photochromic Ligands GPCRs in Neuroscience Conformationally Selective 2-Aminotetralin Ligands Targeting the alpha2A- and alpha2C-Adrenergic GPCRs in Oncology and Immunology Stable Binding of Full-Length Chemerin is Driven by Negative Charges

  • Embark on a GPCR Adventure: Your Weekly Research Expedition! | Oct 21-27, 2024

    De Graaf   for their excellent work on Comparative Study of Allosteric GPCR Binding Sites and Their Ligandability GPCR Forum Conference November 26 - 28, 2024 | GPCRs-Targeted Drug Discovery Summit Europe July 12 - 17 Molecular Insights into GPCR Function Comparative Study of Allosteric GPCR Binding Sites and Their Ligandability

  • Enhanced membrane binding of oncogenic G protein αqQ209L confers resistance to inhibitor YM-254890

    N-terminal mutants of αqQ209L, termed PM-restricted αqQ209L, in which the addition of membrane-binding motifs binding to βγ and decreased binding to regulator RGS2, and effectors p63RhoGEF-DH/PH and phospholipase C

  • 📰 GPCR Weekly News, October 16 to 22, 2023

    November 17: Join our last Dr. GPCR Symposium of the year on GPCRs in Immunology and Oncology! Annual Meeting IRN I-GPCRNet November 2 - 4, 2023 | GPCR Retreat- Registration Closed November 15 - 17 Meeting February 3 - 7, 2024 | SLAS2024 International Conference and Exhibition March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating Conference April 5 - 10, 2024 | AACR Annual Meeting May 13 - 17, 2024 | 20th Annual PEGS Boston Summit

  • 📰 GPCR Weekly News, March 6 to 12, 2023

    Novel Xanomeline-Containing Bitopic Ligands of Muscarinic Acetylcholine Receptors: Design, Synthesis Molecular sensing of mechano- and ligand-dependent adhesion GPCR dissociation. (March 14-17, 2023). SLAS 2023 Building Biology in 3D Symposium. Studentship - Integrated Approaches In Pharmacology, Computer Simulations And Machine Learning To Predict Ligand

  • 📰 GPCR Weekly News, March 4 to 10, 2024

    Webinars March 13 - 15 | Biologics 2024 March 13 - 15 | 9th German Pharm-Tox Summit March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating Chemistry April 4 - 7, 2024 | American Physiology Summit April 5 - 10, 2024 | AACR Annual Meeting May 13 - 17 2024 | 9th GPCRs in Medicinal Chemistry October 23 - 25, 2024 | 11th Adhesion GPCR Workshop July 12 - 17

  • Structural insights into adhesion GPCR ADGRL3 activation and Gq, Gs, Gi, and G12 coupling

    is the removal of the inhibitory GAIN domain and the dipping of the cleaved stalk peptide into the ligand-binding The structures reveal unique ligand-engaging mode, distinctive activation conformation, and key mechanisms

  • Isoforms of GPR35 have distinct extracellular N-termini that allosterically modify...

    employed optical assays in living cells to thoroughly profile both GPR35 isoforms for constitutive and ligand-induced activation and signaling of 10 different heterotrimeric G proteins, ligand-induced arrestin recruitment and mechanistic insights of our study provide clues for the future design of isoform-specific GPR35 ligands

  • GPR110, a receptor for synaptamide, expressed in osteoclasts negatively regulates osteoclastogenesis

    Synaptamide suppressed osteoclastogenesis induced by receptor activator of nuclear factor-kappa B ligand Our study suggested that ligands of GPR110, such as synaptamide, might be a useful drug for osteoporotic

  • Structures of oxysterol sensor EBI2/GPR183, a key regulator of the immune response

    These structures reveal an agonist binding site for the oxysterol and a potential ligand entrance site Together, these findings provide new insight into how EBI2 is activated by an oxysterol ligand and will

  • 📰 GPCR Weekly News, July 10 to 16, 2023

    The head mesodermal cell couples FMRFamide neuropeptide signaling with rhythmic muscle contraction in C. Board of Directors Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c) NEW MPGPCR Conference (November 15 -17, 2023) Structure, Mechanism, and Drug Interactions of GPCRs, Ion

  • Interacting binding insights and conformational consequences of the differential activity of...

    dual contrasting functional feature of CBD, that is, displaying antagonistic and (possible) agonistic ligand From microsecond-length unbiased molecular dynamics simulations, we found that the presence of the CBD ligand These results are in agreement with the proposed modulatory function of each ligand, showing that the In contrast to the CBD/CB1 complex, when the CB1 receptor is simulated in complex with the ligand antagonist

bottom of page